Therapy Areas
16 November 2026 - Biopharmaceutical company Aelis Farma (Euronext: AELIS) announced on Monday that it has received a second positive recommendation from the Independent Data Monitoring Committee (IDMC) following its review of the Phase 2b trial of A...
16 November 2026 - CARsgen Therapeutics Holdings Limited (HK:2171), a Chinese developer of innovative CAR T-cell therapies, announced on Saturday that satricabtagene autoleucel (satri-cel, product code: CT041), an autologous CAR T-cell therapy produc...
16 November 2026 - Ambrosia Biosciences Inc, a drug discovery company developing next-generation oral small molecule therapies for obesity and other metabolic disorders, on Sunday announced nonclinical data in two poster presentations at The Obesity ...
16 November 2026 - Precision medicine oncology company IDEAYA Biosciences Inc (Nasdaq:IDYA) on Sunday announced the development candidate nomination of IDE101, a potential first-in-class dual cyclin-dependent kinase (CDK) inhibitor designed to addres...
16 November 2026 - Biopharmaceutical company Specialised Therapeutics announced on Sunday that the Thailand Food and Drug Administration has approved YONDELIS (trabectedin) for the treatment of adult patients with advanced soft tissue sarcoma (STS).T...
13 November 2026 - Rezolute, Inc. (NASDAQ: RZLT), a late-stage metabolic disease company focused on treating refractory hypoglycemia caused by hyperinsulinism, said preliminary results from a data evaluation show its open-label Phase 3 upLIFT study o...
13 November 2026 - New York-based global type 1 diabetes (T1D) research and advocacy organisation Breakthrough T1D and the Walgreens Foundation announced on Thursday a new national partnership supporting Breakthrough T1D's mission and advancing ...